Potency Concerns Prompt Wedgewood Compounded Veterinary Drug Recall 2026

Pet medications that are too weak may not work, and ones that are too strong can cause toxicity or overdose. That is the central concern behind a nationwide recall of compounded veterinary medications issued by Wedgewood Pharmacy LLC of Swedesboro, New Jersey, announced on October 21, 2026 and posted by the U.S. Food and Drug Administration.

The company is recalling certain compounded veterinary medications that are still within their expiry dates. The recall is being carried out at the provider and customer level, meaning it targets veterinary practices, pharmacies and other customers who received the products.

Recalled Products at a Glance

The recall covers a wide range of compounded veterinary products. According to the announcement, the affected formats include:

• Powders and pastes
• Oral suspensions
• Injectables
• Ophthalmic ointments and solutions
• Ear solutions and suspensions
• Topical sprays and gels

The products have no brand name and are described only as compounded veterinary medications. Because the list is long, the company has published a full lookup of affected products, lot numbers and expiration dates at www.wedgewood.com/recall-lookup/. The FDA notice does not list individual lots, so anyone with a Wedgewood product should check that page directly.

Quick Facts

• Company: Wedgewood Pharmacy LLC, Swedesboro, N.J.
• Announcement date: October 21, 2026
• Shipping window: February 18, 2026 to October 6, 2026
• Distribution: Nationwide in the United States
• Complaints received to date: 98, of which 7 are serious
• Recall hotline: 866-562-5931

What Triggered the Recall

Wedgewood says the recall stems from inconsistencies in the reliability of certain analytical testing data generated by its laboratory. Because that data may not be dependable, the company cannot be sure the affected products contain the intended amount of active ingredient. The result could be products that are subpotent, meaning too weak, or superpotent, meaning too strong.

The company says the issue was discovered through its own quality processes. No specific drug or ingredient has been named as the cause in the announcement.

The Health Risk

The risks depend on which way the potency is off. A subpotent medication may lead to ineffective treatment, which can matter a great deal when an animal is being treated for an infection, pain, a chronic condition or an eye or ear problem. A superpotent medication can lead to toxicity or overdose.

To date, Wedgewood has received 98 complaints, and 7 of them are considered serious. The announcement does not describe the nature of those complaints or the animals involved. Customers with medical concerns about an animal are advised to contact their veterinarians.

Who Should Be Concerned

The affected products were shipped to veterinary practices, pharmacies and other customers across the United States. They are intended for companion animals, horses, exotic animals, zoo animals, wildlife and aquatic animals. They are not intended for use in food-producing animals.

That means the people most likely to be affected include pet owners whose animals were prescribed a compounded medication, equine owners, and clinics or pharmacies that stocked or dispensed Wedgewood products during the shipping window.

What Consumers Need to Do Now

If you are an animal owner who received an affected product, follow these steps:

• Stop using the product, but keep it rather than throwing it away.
• Check the lot number and expiration date against the lookup page at www.wedgewood.com/recall-lookup/.
• Call Wedgewood recall services at 866-562-5931, Monday through Friday 8am to 9pm ET and Saturday 9am to 5pm ET.
• Contact your veterinarian if you have any health concerns about your animal or need help continuing treatment.

Wedgewood has engaged Sedgwick to coordinate the recall. Sedgwick is notifying affected customers by email and mail and is arranging a refund or, where possible, a replacement of recalled products.

Guidance for Veterinary Practices and Pharmacies

Businesses are asked to examine their inventory immediately, quarantine any affected product and call the same recall number. Practices or pharmacies that have already dispensed affected product should identify those customers and notify them of the recall.

Wedgewood says it is also working to help maintain continuity of care, including identifying clinically appropriate alternatives where available. Customers can ask about alternative treatments through Sedgwick at 866-562-5931, and Sedgwick will refer clinical questions to Wedgewood’s care team.

Official Statement

In its announcement, Wedgewood said the recall is being conducted with the knowledge of the U.S. Food and Drug Administration. The FDA notes that it posts company announcements as a public service and does not endorse either the product or the company.

Adverse reactions or quality problems linked to the use of these products may be reported to the FDA at 1-888-FDA-VETS or through the agency’s online animal adverse event reporting page.